Hypercalciuric Hypercalcemia
Hypercalciuric Hypercalcemia
Explore linked clinical trials. Standard reference: MESH:M05636731 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypercalciuria, Hypercalciuric Hypercalcemia, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, Water-Electrolyte Imbalance, calcinosis, calcium metabolic disease, hereditary disease, hypercalcemia disease, hypercalcemia, infantile, kidney disorder, metabolic disease, nephrocalcinosis, urinary system disorder | Recruiting | Phase 2 | 2026-06-22 | NCT03301038 |